PRODUCTION OF -68 generator

A gallium-68 generator is a device used to extract the  -emitting 68Ga of gallium from a source of decaying -68. The parent isotope 68Ge has a half-life of 271 days and can be easily sent to hospitals within the generator, where it is storable for almost a year. Its gallium-68 (with a half- life of only 68 minutes) is extracted and used for certain positron emission tomography diagnostic procedures, where the radioisotope's relatively short half-life and emission of for creation of 3-dimentional PET scans, are useful. Parent isotope (Ge-68) source

The parent isotope germanium-68 is the longest-lived (271 days) of  the radioisotopes of germanium. It has been produced by several methods. In the U.S., it is primarily produced in proton accelerators:

At Brookhaven National Laboratories, 40 MeV proton irradiation of a  gallium metal target produces germanium-68 by proton capture and double neutron knockout, from gallium-69 (the most common of two stable of gallium). This reaction is: Ga-69 + p --> 2n + Ge-68. 

A Russian source produces germanium-68 from accelerator-  produced ion (alpha) irradiation of -66, again after knockout of two neutrons, in the nuclear reaction Zn-66 + alpha --> 2n + Ge-68. Mechanism of generator function

1. When loaded with the partent isotope  germanium-68, these generators function similarly to -99m generators, in both cases using a process similar to thin layer chromatography. The stationary phase is alumina onto which germanium- 68 is adsorbed. The mobile phase is a solvent able to elute (wash out) decayed germanium-68. 2. Currently Ga-68 (III) is easily eluted with a few  mL of 1 M or 0.1M hydrochloric acid from generators, within 1 to 2 minutes. Conclusion:  The PET isotope gallium-98 can be obtained  from germanium-68 – gallium-68 generator. The parent germanium-68 prepared using 30-60  MeV energy and high current has a long half life (271 days) and hence the generator can be  transported over very long distances and useful for periods of up to one year. 

Generator produced PET- radiopharmaceuticals

The availability of PET generators would facilitate  PET studies by those centres that do not have a cyclotron. In addition, it can also enhance the range of studies at existing cyclotron/PET centres.

Gallium-68 is finding use in cancer imaging when labelled with  peptides.

The ultra short-lived -82 (a half-life of 75 seconds),  available from a -82 – rubidium-82 generator, and useful for PET imaging of blood flow to myocardium, Has high potential in managing heart patients.  Characteristics of ideal generator system

1. If intended for clinical use, the output of the generator must .1 be sterile and pyrogen-free . 2. The chemical properties of the daughter must be different than those of the parent to permit separation of daughter from parent. Most often, separations are performed chromatographically . 3. Generator should be eluted with 0.9% saline solution and should involve no violent chemical reactions. . 4. Daughter isotope should be short-lived gamma-emitting nuclide (physical half-life = hrs-days).

5. Physical half-life of parent should be short enough so daughter regrowth after elution is rapid, but long enough for practicality

.  6. Daughter chemistry should be suitable for preparation of a wide variety of compounds, .especially those in kit form.

7. Very long-lived or stable granddaughter so  no radiation dose is conferred to patient by decay of subsequent generations

8. Inexpensive, effective shielding of  generator, minimizing radiation dose to those using it.  9. Easily recharged (we do NOT recharge Mo/Tc generators, but store them in decay areas after their useful life is over.

• The daughter activity grown by the decay of the parent is separated chemically from the parent. • The eluent in vial A is drawn through the column and the daughter nuclide is collected in vial B under vacuum.

Typical generator system The vial containing the eluant is first inverted onto needle A, and another evacuated vial is inverted onto the other needle B. Generator Activity Levels Production of Production   99 Mo/ commercial manufacturer on purchase technetium generators In practice, hospital pharmacies contamination and minimizes chances of radiation exposure personnelof a minimumto means that performed sterile The generators are supplied as a weekly standing 99 m Tc generator

unitsand elutionis automatically manipulation are kept , which reduces, which

Radionuclide Generator -

Elution

order from . This .

100

10 Activity

99 ( 6

m 99 Tc hr)

1 Mo ( Mo

66

2 hr)

Time (days)

3

4

5

6

Faculty of Pharmacy – Assiut University – Fourth Year Elective Course - Radiopharmacy - 2010-2011 – 2nd sem Production of Radionuclides Production  99 Mo/ Steps foreluting thegenerator 99 m Tc generator Radionuclide Generator -

Elution

Faculty of Pharmacy – Assiut University – Fourth Year Elective Course - Radiopharmacy - 2010-2011 – 2nd sem Production of Radionuclides Production     Preparation Tc of contains allthe necessary is asingle,A kit sterile,freeze use To thesimplify preparation of Tc manufacturers instructions accordance withthe pertechnetate sterile by The preparation is achieved 99 can Kits be obtained commercially and are availablefor all Tc prepare aspecific m radiopharmaceuticals.m a single step addition kits sodium

to the kit in the kit to - radiopharmaceuticals Using Kits Radionuclide Generator

of non

- Generator Generator - dried, rubber capped radioactive ingredients - radiopharmaceuticals, we

Generator Generator

elutions elutions

Addition Addition of of elute to kits to kits

vial

radiopharmaceutical

to Ready for Ready for use

which which -

Faculty of Pharmacy – Assiut University – Fourth Year Elective Course - Radiopharmacy - 2010-2011 – 2nd sem Production of Radionuclides Production     Preparation Tc of appropriate volume is dispensed in asterile syringe The dose required for thepatientis and the should vialbe labeled appropriately The radioactivityin the constitutedvialshould be dose will Due to thedecay of Tc patientadministration The activityin thesyringe is measured before is issued it for increase - radiopharmaceuticals Using Kits

Radionuclide Generator during the day - 99

m, them, volume

calculated

required for agiven

and the

measured

Faculty of Pharmacy – Assiut University – Fourth Year Elective Course - Radiopharmacy - 2010-2011 – 2nd sem Production of Radionuclides Production  Preparation Tc of Components kits: of 2. 1. . . . . stannic During reaction,this thestannous ionis oxidized to radiopharmaceutical enters chemical reactions toproduce the Reductiona to which Tc ispresent in the + Itasacts a A stannous salt The compound be to labeled replaced by the addition the elute,of the airin the normally vialis To prevent this oxidationoccurring spontaneously prior to

ion reducing agent

- radiopharmaceuticals Using Kits Radionuclide Generator lowervalency state

for the sodium for thesodium pertechnetate in 7

valency state

is necessaryis before Tc

Faculty of Pharmacy – Assiut University – Fourth Year Elective Course - Radiopharmacy - 2010-2011 – 2nd sem Production of Radionuclides Production  Preparation Tc of Components kits: of . 3. 4. may also be present MaterialscontrolpH to andof the tonicity final injection reconstitutionof the kits To prevent acid Antioxidants such as ascorbic acidpara or

re - radiopharmaceuticals Using Kits - oxidation Radionuclide Generator

of Tc of ahigher to valency stateafter

- aminobenzoic

Faculty of Pharmacy – Assiut University – Fourth Year Elective Course - Radiopharmacy - 2010-2011 – 2nd sem Production of Radionuclides Production  Preparation Tc of Kits offer Kits thefollowingadvantages: 1. 4. 3. 2. radiation exposure. time The single completed by themanufacturer pyrogenicityfor sterility, and labeling efficiency) can be They are theirmanufacture. materials and hence there is of theMost formulation work doneis non with reduced. micro minimal The number of manipulations inthe radiopharmacy is

spent handling radioactive materialand hence - organisms intofinal the preparation is greatly . The . chance introducingof foreign matteror

stable - step additionthe of radionuclide - radiopharmaceuticals Using Kits Radionuclide Generator

and qualityassurance programmes (tests

no radiation exposure prior supply to

minimizes

-

radioactive of thekits

during

Faculty of Pharmacy – Assiut University – Fourth Year Elective Course - Radiopharmacy - 2010-2011 – 2nd sem Production of Radionuclides Production Important Radionuclide Generators

(

( ( (half 25.5 271 115

(

Parent Parent

99 66 113 68 82 Mo Ge Ge Sn Sr days) days) - days) hr) life)

(half

Daughter ( (

(

68

99

113

99 75 ( 82 68 6 m m Rb Ga Ga min) min) - hr) sec) Tc In life) Radionuclide Generator

Transition Transition Daughter Emission Emission Isomeric Isomeric Positron Positron

decay

392

140 511 511 Photon energy

KeV KeV KeV KeV

Column

Al Al

SnO ZrO 2 2 O O 2 2 3 3

solution solution solution solution

Eluent EDTA NaCl NaCl HCl

Faculty of Pharmacy – Assiut University – Fourth Year Elective Course - Radiopharmacy - 2010-2011 – 2nd sem Production of Radionuclides Production    as the Sometimesis confusedit with contains For example, suppose that aradionuclide aor labeled compound. is definedSpecific activity as the . . will have aconcentration of A 55.5 Itsspecific wouldactivity be 10 radioactivityper unitvolume - MBq/mg ml solutioncontaining 150 mCi (

5.55 Specific Activity GBq) 100 131 concentration I radioactivity mg 4.5 45 150 radioactivityper unitmass mCi ( 131 mCi/ml (

/ of asampleof 100 I -

labeledalbumin

1.67 1.67 , thatis, 167 GBq) radioactivity , which is defined

MBq/ml) 1.5 mCi/mg or

of

Faculty of Pharmacy – Assiut University – Fourth Year Elective Course - Radiopharmacy - 2010-2011 – 2nd sem Production of Radionuclides Production   provided on the label posted on the vial. informationfor a particular nuclear medicine testand is often The specific aof radiopharmaceuticalactivity an is important relatedthe tohalf The specific aof carrier activity . The shorter the half - life of the life of radionuclide: Specific Activity - life,the higher the specific activity - free radionuclide sample is

Faculty of Pharmacy – Assiut University – Fourth Year Elective Course - Radiopharmacy - 2010-2011 – 2nd sem Secular Equilibrium

Secular equilibrium: a condition reached when the tphys of the  parent is many times greater than the tphys of the daughter, e.g., 100-1000 times greater. To keep things in perspective, during 10 half-lives of the  daughter, decay of the parent is negligible. Decay of the parent is represented by the flat line in the diagram below. Transient Equilibrium

Transient equilibrium : a condition reached when the tphys of  the parent is approximately 10 times greater than the tphys of the daughter. A classical example is the Mo-99/Tc-99m Generator. During the  67 hr representing 11 half-lives of Tc-99m, 50% of the Mo-99 has disappeared, as noted in the following diagram. In both transient and secular equilibrium, apparent half-life of the daughter = physical half-life of the  parent Transient Equilibrium Between elutions, the daughter (Tc-99m)  builds up as the parent (Mo-99) continues to decay.

After approximately 23 hours the Tc-99m  activity reaches a maximum, at which time the production rate and the decay rate are equal and the parent and daughter are said to be in transient equilibrium

Transient equilibrium occurs when the half-life  of the parent is greater than that of the daughter by a factor of ~10 Secular Equilibrium

If the half-life of the parent is very much longer  than that of the daughter (I.e., more than about 100 longer), secular equilibrium occurs after approximately five to six half-lives of the daughter In secular equilibrium, the activity of the  parent and the daughter are the same if all of the parent atoms decay directly to the daughter Once secular equilibrium is reached, the daughter  will have an apparent half-life equal to that of the parent